Publications
Keeping up with information about toxic adulterants is important. The publications page contains all of the latest information about adulterants that has been disseminated, including research articles published by ITAD members.
Levamisole as Opioid Adulterant in Mice: Lethal, Analgesic and Hematological Effect
A.K. Ruiz-Quiñonez, T. Browne Jr., Z. Espinosa-Riquer, C. González-Espinosa and S.L. Cruz
Read More >
Read More >
Complications Associated with Use of Levamisole-Contaminated Cocaine: An Emerging Public Health Challenge
K.C. Lee, B. Ladizinski and D.G. Federman
Read More >
Read More >
Levamisole in Cocaine: Unexpected News from an Old Acquaintance
A. Larocque and R.S. Hoffman
Read More >
Read More >
Levamisole and Cocaine Synergism: A Prevalent Adulterant Enhances Cocaine's Action In Vivo
C.S. Tallarida, E. Egana, G.D. Alejo, R. Raffa, R.J. Rallarida and S.M. Rawls
Read More >
Read More >
Adultération de la Cocaïne par Le Lévamisole : Quels Risques? / Cocaine Adulterated with Levamisole: What are the Risks?
P. Hantson
Read More >
Read More >
Levamisole-adulterated Cocaine: Two Fatal Case Reports and Evaluation of Possible Cocaine Toxicity Potentiation
F. Indorato, G. Romano and N. Barbera
Read More >
Read More >
Levamisole Adulterated Cocaine and Pulmonary Vasculitis: Presentation of Two Lethal Cases and Brief Literature Review
S.B. Karch, F.P. Busardò, F. Vaiano, F. Portelli, S. Zaami and E. Bertol
Read More >
Read More >
The Netherlands Drug Situation 2014
M. van Laar, G. Cruts, M. van Ooyen-Houben, E. Croes, P. van der Pol, R. Meijer and T. Ketelaars
Read More >
Read More >
Determination of Phenyltetrahydroimidazothiazole Enantiomers (Levamisole/Dexamisole) in Illicit Cocaine Seizures and in the Urine of Cocaine Abusers via Chiral Capillary Gas Chromatography-Flame-ionization Detection: Clinical and Forensic Perspectives
J.F. Casale, V.L. Colley and D.F. Legatt
Read More >
Read More >
United Nations Office on Drugs and Crime: World Drug Report 2015
United Nations Office on Drugs and Crime
Read More >
Read More >